Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
40%
OVERLAP
BY WEIGHT
19
# OF OVERLAPPING
HOLDINGS
GDOC
39
HOLDINGS
51%
ALSO IN FMED
FMED
62
HOLDINGS
35%
ALSO IN GDOC
SECTOR DRIFT (GDOC minus FMED)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GDOC |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
BOSTON SCIENTIFIC CORP | 9.0% | 7.9% | 7.9% |
|
INSULET CORP | 6.1% | 6.0% | 6.0% |
|
INTUITIVE SURGICAL INC | 5.2% | 4.0% | 4.0% |
|
ALNYLAM PHARMACEUTICALS INC | 3.2% | 5.2% | 3.2% |
 |
ARGENX SE ADR | 3.0% | 4.3% | 3.0% |
GDOC Overweight Relative to FMED
|
ELI LILLY & CO | 6.5% |
|
ABBVIE INC | 6.3% |
|
ABBOTT LABORATORIES | 5.1% |
 |
ASTRAZENECA PLC | 4.4% |
|
MERCK & CO. INC. | 3.6% |
|
COOPER COS INC/THE | 3.0% |
 |
HOYA CORP | 3.0% |
|
NEUROCRINE BIOSCIENCES INC | 2.7% |
|
BIOMARIN PHARMACEUTICAL INC | 2.7% |
 |
CSL LIMITED | 2.6% |
GDOC Underweight Relative to FMED
|
UCB SA | -3.4% |
|
PENUMBRA, INC. | -3.3% |
|
STRYKER CORP | -2.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.6% |
|
EDWARDS LIFESCIENCES CORP | -2.5% |
|
REGENERON PHARMACEUTICALS | -2.4% |
|
EXACT SCIENCES CORP | -2.4% |
|
DEXCOM INC | -2.2% |
|
ALNYLAM PHARMACEUTICALS INC | -2.0% |
|
MASIMO CORPORATION | -1.9% |